Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based study-Reference-Cited by-同舟云学术

Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based study

Published:2022-12-30 Issue:3 Volume:43 Page:588-598
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Ho Jacky C. L.¹^ORCID,Mak Joyce W. Y.¹²³,Yip Terry C. F.¹²³,Lam Hong Man²,Cheng Tsz Yan²,Lam Tsz On¹,Tam Lai Shan¹,Law Man Fai¹,Cheung Carmen K. M.¹,Ng Siew C.¹²,Wong Vincent W. S.¹²³,Wong Grace L. H.¹²³

Affiliation:

1. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong Hong Kong

2. Institute of Digestive Disease The Chinese University of Hong Kong Hong Kong Hong Kong

3. Medical Data Analytics Centre The Chinese University of Hong Kong Hong Kong Hong Kong

Funder

Chinese University of Hong Kong

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15499

Reference48 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. Hepatitis B infection in the general population of China: a systematic review and meta-analysis

3. Statements from the Taormina expert meeting on occult hepatitis B virus infection

4. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population-Based Clinical Studies Using Routinely Collected Data in Hong Kong, China: A Systematic Review of Trends and Established Local Practices;Cardiovascular Innovations and Applications;2023